| Name | 3-[2-(4-methylsulfonylphenyl)ethenyl]-1,2,4-oxadiazole |
|---|---|
| Synonyms |
3-(4-Methylsulfonylstyryl)-1,2,4-oxadiazole
1,2,4-Oxadiazole,3-[p-(methylsulfonyl)styryl]-,(E)-(8CI) 1,2,4-Oxadiazole,3-[(1E)-2-[4-(methylsulfonyl)phenyl]ethenyl] 3-trans-p-methylsulphonylstyryl-1,2,4-oxadiazole 1,2,4-Oxadiazole,3-[2-[4-(methylsulfonyl)phenyl]ethenyl]-,(E) 3-(trans-4-methanesulfonyl-styryl)-[1,2,4]oxadiazole 3-[(E)-2-(4-methylsulfonylphenyl)ethenyl]-1,2,4-oxadiazole BTI 2571E |
| Density | 1.362g/cm3 |
|---|---|
| Boiling Point | 479ºC at 760mmHg |
| Molecular Formula | C11H10N2O3S |
| Molecular Weight | 250.27400 |
| Flash Point | 243.5ºC |
| Exact Mass | 250.04100 |
| PSA | 81.44000 |
| LogP | 2.72430 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.592 |
| HS Code | 2934999090 |
|---|
|
~98%
24664-14-0 |
| Literature: Glaxo Laboratories Limited Patent: US4012377 A1, 1977 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |